JW Lifescience Corporation (KRX:234080)

South Korea · Delayed Price · Currency is KRW

12,620

-290 (-2.25%)

Apr 2, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals			206.86B	188.93B	169.82B	183.52B	170.22B
Pharmaceuticals Growth			9.49%	11.26%	-7.47%	7.81%	9.66%
Total			206.86B	188.93B	169.82B	183.52B	170.22B
Total Growth			9.49%	11.26%	-7.47%	7.81%	9.66%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Export			9.34B	-	-	-	-
South Korea			197.18B	-	-	-	-
Unallocated			337.14M	-	-	-	-
Total			206.86B	-	-	-	-

Source: S&P Global Market Intelligence.